African COVID-19 Vaccine Safety Surveillance (ACVaSS)

The GVDN® is a technical partner with the African COVID-19 Vaccine Safety Surveillance (ACVaSS) project.* Hospital-based sentinel surveillance designed to detect safety signals of rare adverse events of special interest (AESIs) or to evaluate safety signals arising from other sources, following vaccination with COVID-19 vaccines, is being implemented in eight in African Advanced Market Commitment-92 (AMC-92) eligible countries in the Alive (African Leadership in Vaccinology Expertise) Network: Mali, Ghana, Nigeria, Ethiopia, Kenya, Malawi, Mozambique, Eswatini.

Assessment of vaccine mediated enhanced disease in epidemiologic studies monitoring COVID-19 vaccines

Assessment of vaccine mediated enhanced disease (VMED) in epidemiologic studies monitoring COVID-19 vaccines is a webinar by the Vaccine monitoring Collaboration for Europe (VAC4EU) and the Brighton Collaboration Safety Platform for Emergency Vaccines (SPEAC) Project.

Picture VAC4EU-SPEAC VMED webinar

How vaccine safety data is constantly misused and what you can do

Helen Petousis-Harris, BSc, PGDipSci (Dist), PhD

Given the breadth and magnitude of vaccine safety activities, it is surprising how wide the belief is that the world relies on voluntary reports of adverse events, even among health professionals. That this science is so misunderstood provides fertile ground for anti-vaccine messages to propagate. Here is some information to help challenge the misconceptions. 

Spiral stairs
Subscribe to